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Gaseous substances constitute a unique class of indis-
pensable biomaterials for maintaining the homeostasis
of biological systems. In particular, the gases, including
nitric oxide (NO), carbon monoxide (CO), hydrogen sul-
fide (H2S), and hydrogen (H2), have well been described
in the last decade as signaling gas molecules, as well as
other important candidates for clinical applications.
Given the fact that those individual gases play critical
roles in biological systems, providing the newest findings
and applications for gas biology basic and clinical
research is of great importance. This book provides
valuable information not only for basic researchers in
physiology and biochemistry, but also for clinicians who
wish to learn more about the role of gaseous mediators.
This book has been published with 32 figures and 11
tables and divided into a preface and seven sections,
listed below. In each section, leading specialists share
their scientific experience in the field, covering a wide
range of topics, including genetic, physiological, and
medical imaging techniques. In each chapter, the
authors take the reader on a vast journey through the
impressive recent advances in gas biology (Figure 1).
The preface provides the background and acknowl-
edgements. Drs. Yoshikawa and Naito have held annual
meetings entitled “Heme Oxygenase Research Forums”
since 2004. These conferences largely expanded and
encouraged CO research, which was generated in the
process of heme degradation by heme oxygenase. The
idea of organizing this type of book was initiated by Dr.
Hideo Ueda, who has been ill for years. As the subject
matter of this book is of importance for gas biology
research, Drs. Yoshikawa and Naito took over and com-
pleted Dr. Hideo’s work.
The first “General” section is composed of three clas-
sic review papers which provide the necessary
introduction to gas biology. The first chapter, entitled
“Roles of Stress-Inducible Carbon Monoxide in the Reg-
ulation of Liver Function,” was written by Dr. Makoto
Suematsu, et al. (pages 1-5). As the liver is a gigantic
resource of CO derived from heme degradation in vivo,
constitutive and inducible CO has been suggested to
regulate porto-sinusoidal vascular and biliary function.
Interestingly, Dr. Suematsu mentioned that cystathio-
nine b-synthase (CBS), a heme-containing enzyme, acts
as a CO sensor. The enzyme CBS is also known to be
an important synthesizer of H2S; therefore this chapter
suggests cross-communication among the biological sig-
naling gas system. Dr. Yoshihisa Urita et al. cover
“Intraluminal Gas and Gastrointestinal Disease” (pages
6-14). Gases are produced while passing through the
gastrointestinal tract, possibly causing abdominal symp-
toms, while gas is continuously removed by eructation,
anal evacuation, absorption through the intestinal
mucosa, and bacterial consumption. Impaired gas move-
ment in the alimentary tract is more closely associated
with abdominal symptoms than is liquid movement.
Intestinal gas is often cited as a major cause of irritable
bowel syndrome (IBS). The last chapter of this section
covers “Therapeutic Medical Gas” (pages 15-23), provid-
ing background and clinical feasibility of various thera-
peutic medical gases, such as NO, CO, H2S, H2, xenon,
helium, and ozone. This chapter includes a table that
lists potential therapeutic medical gases and summarizes
their chemistry or biological effects (page 16).
Section two, entitled “Gas and Medical Application: I.
CO,” starts with the chapter “Analysis of Breath CO and
Application to Hemodynamic Monitoring,” which
describes monitoring methods using exhaled CO and its
physiological roles on alimentary tracts. Dr. Sawano
developed accurate, non-invasive, continuous carboxyhe-
moglobin densitometry by expired gas analysis (pages
24-34). Application of this technique to low-dose car-
boxyhemoglobin dilution achieved minimally invasive
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estimation of cardiac output and circulating blood
volume. In the second chapter, Dr. Naito et al. summar-
ize “CO and Its Application to Gastrointestinal Disease”
(pages 35 to 42). Endogenous and exogenous CO have
been reported to have anti-inflammatory and anti-apop-
totic effects by various mechanisms and are involved in
attenuating colonic mucosal inflammation. Considering
the fact that cigarette smoking protects against the
development of ulcerative colitis, the authors assume
that CO, one of the components of cigarette smoke,
might play an important role in ameliorating colonic
inflammation.
Section three, “Gas and Medical Application: II. NO,”
consists of two chapters written by NO research expert
groups Dr. Maruyama et al. and Dr. Shime et al. This
section focuses on the mechanisms of inhaled NO’s
action and clinical applications, particularly focusing on
persistent pulmonary hypertension of the newborn, pul-
monary hypertension after cardiac surgery, and acute
lung injury/acute respiratory distress syndrome (ALI/
ARDS). A meta-analysis of 12 randomized controlled
trials does not indicate the routine use of inhaled NO in
patients with ARDS, although it is currently performed
as a rescue therapy in patients with severe ARDS
symptoms who require extracorporeal membrane oxyge-
nation. In addition, other clinical indications of inhaled
NO, such as chronic obstructive pulmonary disease
(COPD), heart transplantation, and congestive heart fail-
ure, are listed and discussed.
Like NO and CO, H2S has been recognized not only
as a pollutant, but also as an important gaseous physio-
logical mediator. Section four, entitled “Gas and Medical
Application: III. H2S,” covers the basic/clinical aspects of
H2S regarding the alimentary tract. Dr. Chan Young
Ock et al. discuss “Hydrogen Sulfide in the Gastrointest-
inal Tract: Friend or Foe?” (pages 65-72). They propose
H2S’s great pharmacological potential in the gastroin-
testinal tract. However, they concluded that H2S may be
a double-edged sword in the gastrointestinal tract; it
acts an anti-inflammatory mediator to inhibit leukocyte
activation, but when overproduced, may contribute to
further inflammation in an already inflamed area. Dr.
Tomohisa Takagi et al. discuss “Role of Hydrogen Sul-
fide in Colitis” (pages 73-80). They demonstrate that
H2S has been implicated in the regulation of intestinal
inflammation. Dr Takeuchi et al. focus on the duode-
num and report their work in the chapter entitled
“HCO3
- Stimulatory Action of Hydrogen Sulfide in rat
Duodenum” (pages 81-90). Using a rat duodenum loop
between the pyloric ring and the proximal side of the
outlet of a common bile duct, they showed that NaHS
(H2S donor) increased duodenal HCO3
- secretion via
the mechanism mediated by prostaglandin E2 and NO.
Clinical application of hydrogen gas was discussed in
section five, entitled “Gas and Medical Application: IV.
H2“ (pages 91-99). Hydrogen is one promising gaseous
agent that has come to forefront of research during the
last few years. A number of basic and clinical research-
ers have revealed that hydrogen is an important physio-
logical regulatory factor with antioxidant, anti-
inflammatory, and anti-apoptotic protective effects on
cells and organs, with properties to mitigate various dis-
eases. This section summarizes currently available data
regarding the protective role of hydrogen in medicine.
Carbon-13 (13C) represents the most stable isotope
from a practical point of view. 13C-breath tests have
recently been developed as a non-radioactive alternative
in the clinical setting. In particular, the 13C-labeled urea
breath test has been widely employed clinically to moni-
tor Helicobacter pylori infections. In section 6, two car-
bon-13 research experts provide the chapter entitled
“Gas and Medical Application: V. 13C” (pages 100-117).
They also discuss carbon-13’s advantages and
disadvantages.
Further chapters describe other gases and medical
application in section seven, “Gas and Medical Applica-
tion: VI. Others” (pages 119-143) with useful additions.
Dr. Sasaki et al. report very interesting results in a
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chapter entitled “Acetone Response during Graded and
Prolonged Exercise” (pages 119-124). In expired air,
acetone, one of the ketone bodies, gradually increases
during graded and prolonged exercise in experiments
with healthy human volunteers. Breath acetone levels
correlate with fat oxidation rates during exercise. Dr.
Tsuda et al. discuss a very interesting topic, “Findings of
Skin Gases and Their Possibilities in Healthcare Moni-
toring” (pages 125-132). Skin gas, which is emanated
from human skin, is considered to be another option for
noninvasive clinical monitoring in human healthcare, as
shown in Table 1 (page 126). The skin gases include
acetone, ethanol, hydrogen, ammonia, methane, nitrogen
monoxide, and carbon monoxide. The concentration of
the components in skin gas is closely related to that in
blood, and in some cases, in breath. Lastly, phytoncides,
antimicrobial allelochemic volatile organic compounds
derived from plants, are covered by Dr. Nomura in the
chapter entitled “Phytoncide-Its Properties and Applica-
tions in Practical Use” (pages 133-143). Phytoncides are
used in Inhalation of phytoncides restrains activation of
the circular and sympathetic nervous systems, thereby
reducing stress and reforming mental function, shown
in “forest therapy,” as well as in “aroma therapy”.
In conclusion, Gas Biology Research in Clinical
Research is a fascinating and engrossing book on an
important topic. This well-written book contains con-
temporary information and is organized into a clear and
readable format. Abundant and appropriate references
appear at the end of each chapter. When looking
through the table of contents, I realized that this is one
of those rare books that suits all levels of readers, from
beginner to advanced. Medical gases may have a huge
impact as a novel and innovative therapeutic tool for
unmet medical needs with considerable health burdens.
Although seemingly geared to gas biology scientists, this
book should be read by everyone, especially those who
work in clinical settings. Drs. Naito and Yoshikawa have
certainly fulfilled their goals in editing and writing this
book.
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